Increased serum oxidized low-density lipoprotein levels in pregnancies complicated by gestational diabetes mellitus
- PMID: 26494989
- PMCID: PMC4609321
Increased serum oxidized low-density lipoprotein levels in pregnancies complicated by gestational diabetes mellitus
Abstract
Background: Elevated serum levels of oxidized Low-density Lipoprotein (oxLDL) have been found in type 2 and in poorly controlled diabetic patients. Gestational diabetes mellitus (GDM) has common features with type 2 diabetes.
Objective: The aim of our study was to evaluate the serum levels of oxLDL in women with GDM compared to normal pregnant women.
Materials and methods: In this cross-sectional study, ninety-two subjects were randomly allocated to either GDM (n=46) or control (n=46) groups matched for age, body mass index and parity from March 2013 to March 2014. GDM was diagnosed according to the American Diabetes Association criteria at 24-26 weeks of gestation. OxLDL was measured using enzyme-linked immunosorbent assay. T-test and Pearson correlation coefficients were applied for analyzing the data by using SPSS version 17.
Results: Compared to the controls, significantly higher oxLDL levels were found in the GDM group (17.16 ± 3.71 U/L vs. 8.77 ± 1.84 U/L, respectively, p < 0.001). No significant correlations were found between oxLDL and age and BMI of the patients in the groups.
Conclusion: Our study found significant increase of oxLDL in GDM emphasizing the role of short-term hyperglycemia in the formation of oxLDL during GDM. The importance of aptly diagnosis of GDM in maternal health may also be concluded.
Keywords: Body mass index; Gestational diabetes; Oxidized low-density lipoprotein; Pregnancy.
Similar articles
-
[Analysis of the maternal glucolipid metabolism in twin pregnancies complicated by gestational diabetes mellitus].Zhonghua Fu Chan Ke Za Zhi. 2019 Nov 25;54(11):741-746. doi: 10.3760/cma.j.issn.0529-567x.2019.11.005. Zhonghua Fu Chan Ke Za Zhi. 2019. PMID: 31752456 Chinese.
-
[Maternal serum lipid at 36-42 weeks' gestation and their relationship to newborn weight in pregnant women with gestational diabetes mellitus and type 1 and type 2 diabetes mellitus].Zhonghua Fu Chan Ke Za Zhi. 2004 Oct;39(10):675-7. Zhonghua Fu Chan Ke Za Zhi. 2004. PMID: 16144564 Chinese.
-
Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5702-5710. doi: 10.26355/eurrev_201712_14016. Eur Rev Med Pharmacol Sci. 2017. PMID: 29272006
-
Early Pregnancy Maternal Lipid Profiles and the Risk of Gestational Diabetes Mellitus Stratified for Body Mass Index.Reprod Sci. 2015 Jun;22(6):712-7. doi: 10.1177/1933719114557896. Epub 2014 Nov 12. Reprod Sci. 2015. PMID: 25394643 Free PMC article.
-
[Gestational diabetes mellitus (Update 2019)].Wien Klin Wochenschr. 2019 May;131(Suppl 1):91-102. doi: 10.1007/s00508-018-1419-8. Wien Klin Wochenschr. 2019. PMID: 30980150 Review. German.
Cited by
-
IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway.Metab Brain Dis. 2017 Oct;32(5):1571-1583. doi: 10.1007/s11011-017-0040-2. Epub 2017 Jun 9. Metab Brain Dis. 2017. PMID: 28600633
-
Modified lipoprotein-induced sFlt1 production in human placental trophoblasts is mediated by protein kinase C.Eur J Pharmacol. 2025 Jan 5;986:177138. doi: 10.1016/j.ejphar.2024.177138. Epub 2024 Nov 17. Eur J Pharmacol. 2025. PMID: 39551338
-
Lysophosphatidylcholine Impairs the Mitochondria Homeostasis Leading to Trophoblast Dysfunction in Gestational Diabetes Mellitus.Antioxidants (Basel). 2024 Aug 19;13(8):1007. doi: 10.3390/antiox13081007. Antioxidants (Basel). 2024. PMID: 39199251 Free PMC article.
-
Biosensors for Detection of Human Placental Pathologies: A Review of Emerging Technologies and Current Trends.Transl Res. 2019 Nov;213:23-49. doi: 10.1016/j.trsl.2019.05.002. Epub 2019 May 20. Transl Res. 2019. PMID: 31170377 Free PMC article. Review.
-
Immunoendocrine Dysregulation during Gestational Diabetes Mellitus: The Central Role of the Placenta.Int J Mol Sci. 2021 Jul 28;22(15):8087. doi: 10.3390/ijms22158087. Int J Mol Sci. 2021. PMID: 34360849 Free PMC article. Review.
References
-
- American College of O, Gynecologists Committee on Practice B-O. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol. 2001;98:525–538. - PubMed
-
- American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004;27 Suppl 1:S88–90. - PubMed
-
- Ethier-Chiasson M, Forest JC, Giguère Y, Masse A, Marseille-Tremblay C, et al. Modulation of placental protein expression of OLR1: implication in pregnancy-related disorders or pathologies. Reproduction. 2008;136:491–502. - PubMed
-
- Nakhjavani M, Asgharani F, Khalilzadeh O, Esteghamati A, Ghaneei A, Morteza A, et al. Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus. Am J Med Sci. 2011;341:92–95. - PubMed
-
- Stephens JW, Gable DR, Hurel SJ, Miller GJ, Cooper JA, Humphries SE. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem. 2006;52:446–452. - PubMed
LinkOut - more resources
Full Text Sources